Detalhe da pesquisa
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
2.
EASL position paper on clinical follow-up after HCV cure.
J Hepatol
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38845253
3.
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice.
J Hepatol
; 80(6): 957-966, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307346
4.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
5.
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology.
Hepatology
; 2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399245
6.
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.
Liver Int
; 44(7): 1588-1599, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426262
7.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Gut
; 72(1): 141-152, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933916
8.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Lancet Oncol
; 24(7): e312-e322, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414020
9.
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Liver Int
; 43(12): 2762-2775, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37753540
10.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741640
11.
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
J Hepatol
; 77(1): 128-139, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139400
12.
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Am J Gastroenterol
; 117(11): 1816-1824, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973181
13.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int
; 42(8): 1891-1901, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608939
14.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Hepatol Res
; 52(12): 1050-1059, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960789
15.
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence.
Ann Hepatol
; 27 Suppl 1: 100568, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699987
16.
Antiviral therapy in the palliative setting of HCC (BCLC-B and -C).
J Hepatol
; 74(5): 1225-1233, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582128
17.
SARS-CoV-2 infection in patients with a normal or abnormal liver.
J Viral Hepat
; 28(1): 4-11, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190321
18.
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort.
J Viral Hepat
; 28(8): 1190-1199, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896097
19.
Pattern of macrovascular invasion in hepatocellular carcinoma.
Eur J Clin Invest
; 51(7): e13542, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755196
20.
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals.
Liver Int
; 41(9): 2179-2188, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33908147